Effect of Sodium Concentration of Priming and Rinsing Fluids on Weight Gain

Fluid Overload and Hypertension in Hemodialysis Patients Clinical Trial

Official title:

Effect of Sodium Concentration of Priming and Rinsing Fluids on Interdialytic Weight Gain and Blood Pressure in Hemodialysis Patients: a Prospective Pilot Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01168947
• Other study ID #: 052-10
• Status: Completed
• Phase: N/A
• First received: July 22, 2010
• Last updated: April 10, 2017
• Start date: July 2010
• Est. completion date: November 2012

Study information

• Verified date: April 2017
• Source: Renal Research Institute
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Sodium loading during hemodialysis treatment is common and may contribute to increased interdialytic weight gain and hypertension. Excessive use of isotonic saline (containing 0.9% sodium chloride) is one of the factors that may cause sodium loading. During each hemodialysis session, approximately 400 mL of isotonic saline fluid, representing 1.4 grams of sodium, is used to prime and rinse the extracorporeal circuit, and is often administered to the patient. Switching to a non sodium-containing priming and rinsing fluid could allow for removal of the equivalent amount of sodium.

Switching to a non sodium-containing solution for the priming and rinsing of the extracorporeal circuit can contribute to increased sodium removal during the dialysis treatment and allow for reduced interdialytic weight gain, reduced thirst, and improved blood pressure control.

Description:

This 12 week study consists of 3 phases:

Phase 1 (4 weeks): Observation only. Standard priming/rinsing procedure with isotonic saline Phase 2 (4 weeks): Intervention. Switch to a 5% dextrose solution for priming/rinsing procedure Phase 3 (4 weeks): Switch back to standard priming/rinsing procedure with isotonic saline During the study, blood pressures will be measured in a standardized manner at 2 week intervals, a thirst questionnaire will be completed at the end of each phase, and interdialytic weight gain, in-center pre/post-HD blood pressure and intradialytic symptoms will be recorded, apart for routinely measured parameters.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 17
• Est. completion date: November 2012
• Est. primary completion date: November 2012
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Ambulatory, clinically stable maintenance HD patients on a thrice weekly HD regimen.

• Willing and able to provide written, signed informed consent after the nature of the study has been explained.

• Willing and able to comply with all study procedures.

• Age =18 years.

Exclusion Criteria:

• Diabetes mellitus

• Considerable residual renal function (diuresis > 500 mL/day)

• Simultaneous participation in another clinical study except observational trials

• Any psychological condition which could interfere with the patient's ability to comply with the study protocol

• Expectation that native kidney function will recover

• Impossibility to perform a blood pressure measurement on the upper limb

• Unable to verbally communicate in English

• Scheduled for living donor kidney transplant, change to peritoneal dialysis, home HD or plans to relocate to another center during the study period.

• Life expectancy < 6 months

Related Conditions & MeSH terms

• Fluid Overload and Hypertension in Hemodialysis Patients
• Hypertension
• Weight Gain

Intervention

Other:
• 5% dextrose solution
The extracorporeal circuit of the dialysis machine will be primed and rinsed with a 5% dextrose solution instead of 0.9% saline.

Locations

Country	Name	City	State
United States	Yorkville Dialysis Center	New York	New York

Sponsors (1)

Lead Sponsor	Collaborator
Renal Research Institute

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Interdialytic weight gain		12 weeks
Secondary	Pre and post dialysis blood pressure levels.		12 weeks
Secondary	Intradialytic events.		12 weeks
Secondary	Thirst levels		12 weeks